BeOne Medicines AG (ONC)

NASDAQ: ONC · Real-Time Price · USD

380.52

+10.35 (2.80%)

Oct 20, 2026, 11:50 AM EDT - Market open

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
BRUKINSA Revenue	4.53B	3.93B	2.64B
TEVIMBRA Revenue	807.37M	737.30M	620.84M
XGEVA Revenue	348.66M	305.98M	224.40M
BLINCYTO Revenue	125.30M	104.22M	74.33M
KYPROLIS Revenue	67.95M	74.97M	66.17M
POBEVCY Revenue	44.17M	47.40M	53.51M
REVLIMID Revenue	-	-	36.03M
Other Product Revenue	-	-	60.04M
Total Other Product Revenue	115.66M	83.69M	96.07M
Total Product Revenue	6.04B	5.28B	3.78B
Collaboration Revenue	90.39M	60.97M	30.70M
Revenue (Total)	6.13B	5.34B	3.81B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
U.S. Revenue	3.32B	2.88B	1.96B
China Revenue	1.83B	1.68B	1.41B
Europe Revenue	743.18M	611.37M	362.63M
Rest of World Revenue	245.63M	171.81M	78.81M
Rest of World Revenue (Pre-Q3 2022 Reporting)	988.81M	783.18M	441.44M
Revenue (Total)	6.13B	5.34B	3.81B